Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome

Table 1

Description of NS patients and controls.

	Age	Gender	%	Treatment	%	Proteinuria
Nephrotic syndrome	5.58 (range 2–12 years)	Males	52	SSNS	68.75	4.01 g/24 h
		Females	48	SRNS	31.25
Healthy subjects	9 (range 3–12 years)	Males	30.77	No treatment		<0.3 g/L
		Females	69.23

SSNS: steroid-sensitive nephrotic syndrome; SRNS: steroid-resistant nephrotic syndrome.